This study is not yet open for participant recruitment.
Verified by National Cancer Institute (NCI), August 2010
Purpose
Purpose
RATIONALE: RO4929097 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
PURPOSE: This phase II trial is studying
the side effects and how well RO4929097 works in treating patients with
recurrent and/or metastatic epithelial ovarian cancer, fallopian tube
cancer, or primary peritoneal cancer.